Literature DB >> 27991903

Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B.

Ke Shi1,2,3, Michael A Carpenter1,2,3,4,5, Surajit Banerjee6, Nadine M Shaban1,2,3,4, Kayo Kurahashi1,2,3, Daniel J Salamango1,2,3,4, Jennifer L McCann1,2,3,4, Gabriel J Starrett1,2,3,4, Justin V Duffy1,2,3, Özlem Demir7, Rommie E Amaro7, Daniel A Harki2,8, Reuben S Harris1,2,3,4,5, Hideki Aihara1,2,3.   

Abstract

APOBEC-catalyzed cytosine-to-uracil deamination of single-stranded DNA (ssDNA) has beneficial functions in immunity and detrimental effects in cancer. APOBEC enzymes have intrinsic dinucleotide specificities that impart hallmark mutation signatures. Although numerous structures have been solved, mechanisms for global ssDNA recognition and local target-sequence selection remain unclear. Here we report crystal structures of human APOBEC3A and a chimera of human APOBEC3B and APOBEC3A bound to ssDNA at 3.1-Å and 1.7-Å resolution, respectively. These structures reveal a U-shaped DNA conformation, with the specificity-conferring -1 thymine flipped out and the target cytosine inserted deep into the zinc-coordinating active site pocket. The -1 thymine base fits into a groove between flexible loops and makes direct hydrogen bonds with the protein, accounting for the strong 5'-TC preference. These findings explain both conserved and unique properties among APOBEC family members, and they provide a basis for the rational design of inhibitors to impede the evolvability of viruses and tumors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27991903      PMCID: PMC5296220          DOI: 10.1038/nsmb.3344

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  76 in total

Review 1.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

2.  The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.

Authors:  Shingo Kitamura; Hirotaka Ode; Masaaki Nakashima; Mayumi Imahashi; Yuriko Naganawa; Teppei Kurosawa; Yoshiyuki Yokomaku; Takashi Yamane; Nobuhisa Watanabe; Atsuo Suzuki; Wataru Sugiura; Yasumasa Iwatani
Journal:  Nat Struct Mol Biol       Date:  2012-09-23       Impact factor: 15.369

3.  A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.

Authors:  Vincent Caval; Rodolphe Suspène; Milana Shapira; Jean-Pierre Vartanian; Simon Wain-Hobson
Journal:  Nat Commun       Date:  2014-10-09       Impact factor: 14.919

4.  Three-dimensional structure of the R115E mutant of T4-bacteriophage 2'-deoxycytidylate deaminase.

Authors:  Rami Almog; Frank Maley; Gladys F Maley; Robert Maccoll; Patrick Van Roey
Journal:  Biochemistry       Date:  2004-11-02       Impact factor: 3.162

5.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

6.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

7.  1.92 Angstrom Zinc-Free APOBEC3F Catalytic Domain Crystal Structure.

Authors:  Nadine M Shaban; Ke Shi; Ming Li; Hideki Aihara; Reuben S Harris
Journal:  J Mol Biol       Date:  2016-04-30       Impact factor: 5.469

8.  Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.

Authors:  Markus-Frederik Bohn; Shivender M D Shandilya; John S Albin; Takahide Kouno; Brett D Anderson; Rebecca M McDougle; Michael A Carpenter; Anurag Rathore; Leah Evans; Ahkillah N Davis; Jingying Zhang; Yongjian Lu; Mohan Somasundaran; Hiroshi Matsuo; Reuben S Harris; Celia A Schiffer
Journal:  Structure       Date:  2013-05-16       Impact factor: 5.006

Review 9.  Molecular mechanisms of antibody somatic hypermutation.

Authors:  Javier M Di Noia; Michael S Neuberger
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

Review 10.  The AID/APOBEC family of nucleic acid mutators.

Authors:  Silvestro G Conticello
Journal:  Genome Biol       Date:  2008-06-17       Impact factor: 13.583

View more
  97 in total

1.  Computational Investigation of APOBEC3H Substrate Orientation and Selectivity.

Authors:  Mark A Hix; G Andrés Cisneros
Journal:  J Phys Chem B       Date:  2020-05-04       Impact factor: 2.991

2.  Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA.

Authors:  William C Solomon; Wazo Myint; Shurong Hou; Tapan Kanai; Rashmi Tripathi; Nese Kurt Yilmaz; Celia A Schiffer; Hiroshi Matsuo
Journal:  Nucleic Acids Res       Date:  2019-08-22       Impact factor: 16.971

3.  Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features.

Authors:  Rémi Buisson; Adam Langenbucher; Danae Bowen; Eugene E Kwan; Cyril H Benes; Lee Zou; Michael S Lawrence
Journal:  Science       Date:  2019-06-28       Impact factor: 47.728

4.  Mechanisms for targeted, purposeful mutation revealed in an APOBEC-DNA complex.

Authors:  Emily K Schutsky; Zachary M Hostetler; Rahul M Kohli
Journal:  Nat Struct Mol Biol       Date:  2017-02-06       Impact factor: 15.369

5.  Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.

Authors:  Fumiaki Ito; Yang Fu; Shen-Chi A Kao; Hanjing Yang; Xiaojiang S Chen
Journal:  J Mol Biol       Date:  2017-05-04       Impact factor: 5.469

6.  APOBEC3H Subcellular Localization Determinants Define Zipcode for Targeting HIV-1 for Restriction.

Authors:  Daniel J Salamango; Jordan T Becker; Jennifer L McCann; Adam Z Cheng; Özlem Demir; Rommie E Amaro; William L Brown; Nadine M Shaban; Reuben S Harris
Journal:  Mol Cell Biol       Date:  2018-11-13       Impact factor: 4.272

7.  Efficient base editing in methylated regions with a human APOBEC3A-Cas9 fusion.

Authors:  Xiao Wang; Jianan Li; Ying Wang; Bei Yang; Jia Wei; Jing Wu; Ruixuan Wang; Xingxu Huang; Jia Chen; Li Yang
Journal:  Nat Biotechnol       Date:  2018-08-20       Impact factor: 54.908

8.  Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment.

Authors:  Laura Evgin; Amanda L Huff; Timothy Kottke; Jill Thompson; Amy M Molan; Christopher B Driscoll; Matthew Schuelke; Kevin G Shim; Phonphimon Wongthida; Elizabeth J Ilett; Karen Kaluza Smith; Reuben S Harris; Matt Coffey; Jose S Pulido; Hardev Pandha; Peter J Selby; Kevin J Harrington; Alan Melcher; Richard G Vile
Journal:  Cancer Immunol Res       Date:  2019-04-02       Impact factor: 11.151

9.  APOBEC3A Loop 1 Is a Determinant for Single-Stranded DNA Binding and Deamination.

Authors:  Samantha J Ziegler; Yingxia Hu; Swapnil C Devarkar; Yong Xiong
Journal:  Biochemistry       Date:  2019-09-03       Impact factor: 3.162

10.  Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.

Authors:  Shurong Hou; Tania V Silvas; Florian Leidner; Ellen A Nalivaika; Hiroshi Matsuo; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2018-12-11       Impact factor: 6.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.